The TIMI 9b and GUSTO IIb trials and the 'thrombin hypothesis'

Journal of Thrombosis and Thrombolysis

Volumn 4, Issue 3-4, 1997, Pages 311-313

  Andreotti, F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Heparin; Hirudin; Myocardial infarction; Thrombin; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; THROMBIN; THROMBIN INHIBITOR;

ACUTE HEART INFARCTION; ANTICOAGULATION; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; META ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0030793731     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008895827320     Document Type: Short Survey

References (12)

1. Becker RC. Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III. J Thromb Thrombolysis 1995;2:29-36.
2. Cannon CP. Hirudin in acute myocardial infarction. J Thromb Thrombolysis 1995;1:259-267.
3. Antman EM, Braunwald E. Trials and tribulations of thrombin. Eur Heart J 1996;17:971-973.
4. White HD, Yusuf S. Issues regarding the use of heparin following streptokinase therapy. J Thromb Thrombolysis 1995;2:5-10.
5. Granger CB, Hirsh J, Califf R, et al., for the Gusto-I Investigators. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I trial. Circulation 1996;93:870-878.
6. Gold HK, Torres FW, Garabedian HD, et al. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol 1993;21:1039-1047.
7. Andreotti F, Kluft C, Hackett DR, Davies GJ, Maseri A. Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator. Lancet 1993;ii:937-938.
8. Ridker PM, Hebert PR, Fuster V, Hennekens CH. Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction? Lancet 1993;341:1574-1574.
9. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat unstable angina. N Engl J Med 1988;319:1105-1111.
10. Verheught FWA, Marsh RC, Veen G, Bronzwaer JGF, Zijlstra F. Megadose bolus heparin as reperfusion therapy for acute myocardial infarction: Results of the HEAP pilot study. Circulation 1995;92(8):I-415.
11. Andreotti F. Procoagulant and fibrinolytic factors in blood: Relation to the pathogenesis and treatment of acute coronary occlusion in man. PhD thesis, Leiden University, p. 80 (ISBN 90-5412-006-1).
12. Gulba DC, Barthels M, Westhoff-Bleck M, et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction: Relevance for the success of therapy. Circulation 1991;83:937-944.